Microbiology
-
Nucleocapsid 203 mutations enhance SARS-CoV-2 immune evasion
This article has 14 authors:Reviewed by ScreenIT
-
Efficacy of antiviral drugs against the omicron variant of SARS-CoV-2
This article has 9 authors:Reviewed by ScreenIT
-
Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity
This article has 225 authors:Reviewed by ScreenIT
-
Neutralization against Omicron SARS-CoV-2 from previous non-Omicron infection
This article has 8 authors:Reviewed by ScreenIT
-
Structural flexibility of the SARS-CoV-2 genome relevant to variation, replication, pathogenicity, and immune evasion
This article has 2 authors:Reviewed by ScreenIT
-
The roles of APOBEC-mediated RNA editing in SARS-CoV-2 mutations, replication and fitness
This article has 7 authors:Reviewed by ScreenIT
-
ACE2-independent SARS-CoV-2 infection and mouse adaption emerge after passage in cells expressing human and mouse ACE2
This article has 7 authors:Reviewed by ScreenIT
-
A highly sensitive cell-based luciferase assay for high-throughput automated screening of SARS-CoV-2 nsp5/3CLpro inhibitors
This article has 17 authors:Reviewed by ScreenIT
-
Unraveling the antiviral activity of plitidepsin against SARS-CoV-2 by subcellular and morphological analysis
This article has 16 authors:Reviewed by ScreenIT
-
Neutralization and Stability of SARS-CoV-2 Omicron Variant
This article has 16 authors:Reviewed by ScreenIT